Gland Pharma Share Price

Gland Pharma Limited is an India-based generic injectables manufacturer. The Company specializes in sterile injectables, oncology, and ophthalmic, with a specific focus on complex injectables, New Chemical Entities (NCE)-1s, First-to-File products, and 505(b)(2) filings. The Company manufactures a range of dosage formulations, including solutions, suspensions, and lyophilized products. Its product portfolio includes delivery methods such as pre-filled syringes, vials, ampoules, bags, and dry powder injections. It also produces generic injectables in liquid, lyophilized, suspension, and pre-filled syringe forms. Its molecules include Enoxaparin Sodium, Cisplatin, Lacosamide, Rocuronium Bromide, Zoledronic Acid, Vancomycin, and others. Its therapeutic products categories include Anti Malarials, Anti-Infectives, Anti-Neoplastics, Gynecological, Hormones, and others. The Company functions primarily on a business-to-business model. Its subsidiary is Gland Pharma International Pte. Ltd.As of 25 May 2026, Gland Pharma share price is ₹2,333.80. The stock opened at ₹2,369.80, compared to its previous close of ₹2,334.00. During today's trading session, Gland Pharma share price moved in the range of ₹2,321.10 to ₹2,396.00, with an average price of ₹2,358.55 for the day. Looking at its last 52-week, the stock has touched a low of ₹2,321.10 and a high of ₹2,396.00. On the performance front, Gland Pharma share price has increased by 30.87% over the last six months and is up 52.67% on a year-on-year basis.

The market capitalization of Gland Pharma is ₹38,375 Crs, with a P/E ratio of 37.4 and a dividend yield of 0.86%.